GetPortalImpactFactorByIdResp(projectId=1, id=75c313097, cover=https://img.medsci.cn/images/journal/cover/2021/DpD_202109271316068490.jpg, fullname=Molecular Therapy-Oncolytics, abbr=MOL THER-ONCOLYTICS, pyear=暂无数据, frequence=null, articleNumbers=598, citedSelf2015=3.3, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均4.14月, reviewFee=3500.0, pageFee=3500.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2372-7705, greenSci=https://www.greensci.net/search?kw=2372-7705, scijournal=https://www.scijournal.org/impact-factor-of-MOL-THER-ONCOLYTICS.shtml, medsciHotlightString=null, medsciHotlightRealtime=3.95, medsciHotlight=12.014, medsciHotlight5year=5.87521, citescore=0.0, hIndex=23, impactFactor=5.7, orgnization=Cell Press, orgnizationUrl=, country=United States, countryCn=美国, isOa=1, isOaString=是, sciScie=, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=http://www.cell.com/molecular-therapy-family/oncolytics/latest-content, websiteHits=3773, guideForAuthor=http://www.cell.com/pb-assets/journals/society/molecular-therapy/Authors_MTO.pdf, guideForAuthorHits=667, submitWebsite=https://mto.msubmit.net/cgi-bin/main.plex, submitWebsiteHits=2156, content=<h2 style="margin: 1em 0px; font-size: 22px; line-height: normal; text-rendering: optimizeLegibility; font-stretch: normal; user-select: text !important; color: rgb(0, 63, 45) !important; font-family: Garamond, times, serif !important;">Molecular Therapy</h2><p style="margin: 0px 0px 1.2em; line-height: 1.4em; color: rgb(51, 51, 51); font-family: arial, sans-serif; font-size: 13px; user-select: text !important;"><em style="user-select: text !important;">Molecular Therapy </em>is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy''s 2015 impact factor is 6.938.</p><h2 style="margin: 1em 0px; font-size: 22px; line-height: normal; text-rendering: optimizeLegibility; font-stretch: normal; user-select: text !important; color: rgb(0, 63, 45) !important; font-family: Garamond, times, serif !important;">Molecular Therapy — Oncolytics</h2><p style="margin: 0px 0px 1.2em; line-height: 1.4em; color: rgb(51, 51, 51); font-family: arial, sans-serif; font-size: 13px; user-select: text !important;"><em style="user-select: text !important;">Molecular Therapy—Oncolytics</em> is an international, online-only, open-access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the burgeoning fields of oncolytic virotherapy, as well as T cell- and stem cell-based therapies, the journal will consider all top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses,  other microorganisms, vaccination, or transfer of cells and/or genes. As an official journal of the American Society of Gene & Cell Therapy, <em style="user-select: text !important;">Molecular Therapy—Oncolytics</em> will build upon the success of <em style="user-select: text !important;">Molecular Therapy</em> and its sibling journals in publishing important peer-reviewed original research and editorial commentary.</p>, totalCites=3412, brief=MOL THER-ONCOLYTICS杂志医学行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=MOL THER-ONCOLYTICS在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=75c313097'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=5), ImpactFactorTagDto(id=108156, tagName=肿瘤放射生物学, createdHits=1), ImpactFactorTagDto(id=44, tagName=医学, createdHits=1), ImpactFactorTagDto(id=6153, tagName=基础, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.17), GetImpactFactorCiteScoreListResponse(year=2018, citescore=37.26), GetImpactFactorCiteScoreListResponse(year=2019, citescore=6.7), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=8.431), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=11.418), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=9.288), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=4.62), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=3.95)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=6/232), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=41/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=21/165), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=38/191)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2372-7705[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Molecular Therapy-Oncolytics[ta], article_number=157, article_number_cn=73, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)